Nanchang Xie

Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial

Chuanjie Wu, Yajun Lian, Yake Zheng et al. · Cephalalgia · 2012 · 214 citations

Medicine, Neurology, Pharmacotherapy +17

Curcumin Improves Amyloid β-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway

Lu Zhang, Yu Fang, Yuming Xu et al. · PLoS ONE · 2015 · 186 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial

Haifeng Zhang, Yajun Lian, Yunqing Ma et al. · The Journal of Headache and Pain · 2014 · 167 citations · Full text

Medicine, Neurosurgery, Pharmacotherapy +16

LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells

Yuan Chen, Yajun Lian, Yunqing Ma et al. · NeuroToxicology · 2017 · 102 citations

Life Sciences, Molecular Genetics, Neuroscience +13

Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis

Chuanjie Wu, Chenghe Sun, Lijun Wang et al. · Stroke · 2019 · 80 citations

Pharmacy, Neurology, Pharmacotherapy +17